Genes2Me Blog – CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems

Genes2Me Blog – CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems

Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical/Whole Exome

Skip to content
Menu
  • Home
  • Visit Genes2Me

Author: Genes2Me

Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry’s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics—delivering integrated solutions that advance precision medicine and improve lives worldwide.
BRCA1 & BRCA2 Gene Mutation - RT-PCR Kit
Awareness MonthPosted onMay 25, 2026May 25, 2026

Empowering Early Detection in Women’s Health with BRCA Q RT-PCR Kit

Women’s health is evolving beyond symptom-based care toward a more proactive and preventive approach. Among the most critical areas of focus today is hereditary cancer…

Read More
Liquid Biopsy - NGS Assays
Dignostic SolutionPosted onMay 7, 2026June 17, 2026

Catching Cancer Early: Liquid Biopsy and NGS at the Frontline of Detection

In oncology, timing is everything. Even with treatment improvements, many cancers are still being diagnosed too late for effective action. Early cancer diagnosis is a…

Read More
Next Generation Sequencing Solution
DiagnosticsPosted onApril 28, 2026April 28, 2026

Redefining Diagnostics with Next-Generation Sequencing: The Genes2Me Advantage

Modern healthcare is shifting toward precision, speed, and data-driven decision-making. At the center of this transformation, Next Generation Sequencing is redefining how diseases are understood,…

Read More
EZY AutoPrep - NGS Assays
DiagnosticsPosted onApril 23, 2026April 24, 2026

Automated NGS Library Preparation System: A Complete Guide to EZY AutoPrep-48

Next-Generation Sequencing (NGS) has transformed modern genomics, enabling rapid and accurate decoding of genetic information. However, one of the most critical and time-consuming steps in…

Read More
Culture Free Sepsis AMR Detection Solution
DiagnosticsPosted onApril 17, 2026May 28, 2026

From Direct Blood to Results in ~2 Hours: A Comprehensive RT-PCR Approach to Culture-free Sepsis and AMR Detection

Sepsis and AMR is one of the most urgent and complex challenges in modern medicine. Despite advances in critical care and infectious disease management, it…

Read More
Diagnostic Ecosystem for TB Control
ManufacturingPosted onApril 2, 2026May 28, 2026

Closing the Diagnostic Gap in Tuberculosis: Why Molecular Diagnostics Matters More Than Ever

On World TB Day, conversations often focus on awareness. However, one of the most critical challenges in tuberculosis (TB) control is delayed and inadequate diagnosis.…

Read More
One-RT-PCR Testing Solution
DiagnosticsPosted onJune 13, 2025May 28, 2026

STI Detection: Ensuring Early Diagnosis for Better Health Outcomes

Sexually transmitted infections (STIs) are a significant global health concern, affecting millions of people each year. According to the World Health Organization (WHO), more than…

Read More
Fully Automated Detection System
DiagnosticsPosted onNovember 28, 2024May 28, 2026

Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency

G2M is excited to introduce OnePCR, a fully automated detection system that transforms point-of-care testing. With its innovative design, OnePCR offers a simplified sample-to-result process…

Read More
POCT Testing Solutions
COVID-19 Testing KitPosted onAugust 2, 2024May 28, 2026

Point-of-Care Testing – Revolutionizing Clinical Diagnostics and Enhancing Patient Care

Point-of-care testing (POCT) has emerged as a game-changer in the realm of clinical diagnostics, offering healthcare professionals the ability to obtain rapid and reliable diagnostic…

Read More
NIPT Testing Solutions
DiagnosticsPosted onMay 4, 2024May 27, 2026

Non-Invasive Prenatal Testing (NIPT) and Its Benefits in Prenatal Care

From the moment those two pink lines appear on the pregnancy test, expectant parents embark on a journey of anticipation, dreams, hopes, and a myriad…

Read More

Posts navigation

Previous Page Page 1 Page 2 Page 3 … Page 7 Next Page

Please enable JavaScript in your browser to complete this form.
Name *
Loading

Recent Posts

  • One gene panel. Three diagnoses sorted out. No guessing.
  • From Early Detection to Deeper Understanding: The Changing Landscape of Blood Cancer
  • Decoding Lung Cancer: Precision Genomics with FOCUS Lung & CliSeq
  • Advanced by Nature. Flexible by Design. Meet the RapiCycler 96 — Real-Time PCR System
  • From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter

Categories

  • Antibody Test
  • Awareness Month
  • blood cancer
  • BRCA Gene Testing
  • COVID Antibody Test
  • COVID-19 RT PCR Test
  • COVID-19 Testing Kit
  • CYSTIC FIBROSIS
  • Diagnostics
  • Dignostic Solution
  • DNA RNA Solutions
  • Exome Sequencing
  • Extraction Solution
  • Genes2Health
  • Genetic Testing
  • Hepatitis
  • Manufacturing
  • Microarray
  • Mother and Child Care
  • Newborn Screening
  • Next Generation Sequencing
  • NGS Assays
  • NIPT
  • Oncology
  • PCR
  • Personalized Genomics
  • Point of Care Solution
  • Real Time PCR Solutions
  • RT-PCR IVD Solutions
  • RT-PCR Kit
  • TB Diagnostics NGS
  • Whole Exome
© Copyright 2020 – Genes2Me
Allium Theme by TemplateLens ⋅ Powered by WordPress